| Purpose | Board Meetings Date | Announcement Date | 
|---|---|---|
| Board Meeting | 6 Oct 2025 | 6 Oct 2025 | 
| Outcome of Meeting of the Board of Directors held on Monday, October 06, 2025, with respect to change in registered office. Clarification with respect to outcome of board meeting held on October 06, 2025. (As Per Bse Announcement dated on 10/10/2025) | ||
| Board Meeting | 4 Oct 2025 | 4 Oct 2025 | 
| Board hereby considered and approved shifting of Registered Office of the Company within local limits. | ||
| Board Meeting | 30 Sep 2025 | 30 Sep 2025 | 
| The Board: 1. Considered and approved alteration of Object Clause in Memorandum of Association of the Company. 2. Considered and approved the adoption of new set of Memorandum of Association and Articles of Association of the company 3. Considered and approved the adoption of new set of Articles of Association. 4. Any other business matter with the permission of Chair. | ||
| Board Meeting | 24 Sep 2025 | 19 Sep 2025 | 
| Mardia Samyoung Capillary Tubes Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/09/2025 inter alia to consider and approve 1. To consider and evaluate the proposal for fund raising by way of issue of any instrument or securities through qualified institutional placement private placement/ preferential issue of securities/Right issue or through any other permissible mode and/ or combination thereof as may be considered appropriate subject to such regulatory approvals as may be required including the approval of the members at a general meeting or through postal ballot and further subject to such statutory / regulatory approvals as applicable. 2. Any other business matter with the permission of Chair. Outcome of the Meeting of the Board of Directors held on 24.09.2025 (As Per Bse Announcement dated on 24/09/2025) Revised outcome of Board meeting held on September 24, 2025 (As Per BSE Announcement Dated on 29.09.2025) | ||
| Board Meeting | 20 Sep 2025 | 20 Sep 2025 | 
| Considered and approved the shifting of the Corporate Office of the Company. (As Per BSE Announcement Dated On : 20.09.2025) | ||
| Board Meeting | 30 Aug 2025 | 30 Aug 2025 | 
| With reference to the captioned subject, we wish to inform your good office that the Board of Directors of the Company, at their meeting held today i.e., Saturday, August 30, 2025, have, inter alia, transacted and approved the following businesses: 01. Approved the Draft Directors Report for the financial year ended March 31, 2025. 02. Notice of 33rd Annual General Meeting Clarification with respect to Board Meeting Outcome dated August 30, 2025. (As Per Bse Announcement dated on 12/09/2025) | ||
| Board Meeting | 29 Aug 2025 | 29 Aug 2025 | 
| Pursuant to Regulation 30 of SEBI LODR, 2015 the Company has appointed Ms. Sonal Vaghela as Non-Executive - Independent Director of the Company. | ||
| Board Meeting | 12 Aug 2025 | 5 Aug 2025 | 
| Mardia Samyoung Capillary Tubes Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve Mardia Samyoung Capillary Tubes Company Limited has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended 30th June 2025. Unaudited Standalone Financial Results of the company for the Quarter ended June 30, 2025 (As Per BSE Announcement Dated on:12.08.2025) | ||
| Board Meeting | 30 May 2025 | 22 May 2025 | 
| Mardia Samyoung Capillary Tubes Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve To consider and to approve the audited financial results of the Company for the financial Year ended March 31 2025 pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 OUTCOME OF BOARD MEETING DATED 30TH MAY, 2025 FOR APPROVAL OF AUDITED FINANCIAL RESULTS FOR THE FINANCIAL YEAR 2024 - 2025 (As per BSE Announcement Dated on 30/05/2025) | ||
| Board Meeting | 27 Feb 2025 | 27 Feb 2025 | 
| Appointment of Additional Directors, Managing Director, Company Secretary cum Compliance Officer, Chief Financial Officer. | ||
| Board Meeting | 14 Feb 2025 | 11 Feb 2025 | 
| MARDIA SAMYOUNG CAPILLARY TUBES COMPANY LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve Quarterly Results for Quarter Ending 31st December 2024. Outcome of the meeting held on 14th February 2025 for approval of Unaudited Financial Results for Quarter ending 31st December 2024 (As Per BSE Announcement Dated on: 14/02/2025) | ||








 IIFL Customer Care Number
 IIFL Customer Care Number 
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000  / 7039-050-000
 IIFL Capital Services Support WhatsApp Number
 IIFL Capital Services Support WhatsApp Number
+91 9892691696


IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.